Narya is an early-stage venture capital firm focused on using technology and science to solve for the future, investing in sectors such as life sciences, defense technologies, agriculture, insurance, and robotics. Founded by J.D. Vance and Colin Greenspon, the firm is based in Cincinnati, Ohio and targets startups in under-served regions outside of Silicon Valley.
Deal activity increased 150% year-over-year (5 deals in the last 12 months). Average disclosed round size is $120.0M (across 15 rounds with reported amounts).
Portfolio
15
Fund Size
$93M
Top Stage
Series A
Last 12 Mo
5
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
18 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| NNext Chapter | Series E | $100M | Apr 2026 |
 Valinor | Series A | $54M | Jan 2026 |
| VValinor Enterprises | Series A | $54M | Jan 2026 |
 Peptilogics | Series B | $78M | Oct 2025 |
 Kriya Therapeutics | Series D | $320M | Sep 2025 |
 True Anomaly | Series C | — | Apr 2025 |
 Reprogram Biosciences | Seed | $6M | Jan 2025 |
| SStrive Enterprises, Inc. | Series B | $30M | Jul 2024 |
| True Anomaly | Series D | — | Dec 2023 |
 Atomic Industries | Seed | $17M | Dec 2023 |
| True Anomaly | Series A | $17M | Apr 2023 |
| True Anomaly | Series B | $100M | Jan 2023 |
 Branch | Series C | $147M | Jun 2022 |
 Rumble | Unknown | — | May 2021 |
 AcreTrader | Series A | $12M | Mar 2021 |
 Kriya Therapeutics | Series A | $80M | — |
| BBeren Therapeutics P.B.C. | Growth | $135M | — |
 Decisive | Series D | $650M | — |
Top Co-Investors
Accel5 shared
Eclipse5 shared
Champion Hill Ventures4 shared
ACME Capital4 shared
Menlo Ventures4 shared
645 Ventures4 shared
Founders Fund4 shared
Root Ventures3 shared
Space VC3 shared
Riot Ventures3 shared
XYZ Venture Capital3 shared
Fifth Down Capital3 shared
Meritech Capital2 shared
Rocketship VC2 shared
FiveNine Ventures2 shared
Red Cell Partners2 shared
Friends & Family Capital2 shared
General Catalyst2 shared
Anthemis1 shared
Acrew Capital1 shared
Last updated: 8 September 2026